Skip to product information
1 of 1

Shulph Ink

CRISPR-/Cas9 Based Genome Editing for Treating Genetic Disorders and Diseases

CRISPR-/Cas9 Based Genome Editing for Treating Genetic Disorders and Diseases

YOU SAVE £4.20

Regular price £100.80 GBP
Regular price £105.00 GBP Sale price £100.80 GBP
4% OFF Sold out
Tax included. Shipping calculated at checkout.
  • Condition: Brand new
  • UK Delivery times: Usually arrives within 2 - 3 working days
  • UK Shipping: Fee starts at £2.39. Subject to product weight & dimension
Trustpilot 4.5 stars rating  Excellent
We're rated excellent on Trustpilot.
  • More about CRISPR-/Cas9 Based Genome Editing for Treating Genetic Disorders and Diseases


CRISPR/Cas9 is a powerful genome editing technology that has revolutionized genetic research and has the potential to treat genetic diseases. Its current state of the art, clinical applications, and future prospects are discussed in this article.

Format: Hardback
Length: 262 pages
Publication date: 31 January 2022
Publisher: Taylor & Francis Ltd


The field of genome editing technologies has seen significant advancements in recent years, revolutionizing the way we study and manipulate genetic information. These technologies, including CRISPR/Cas9, have opened up new possibilities for basic and applied research, as well as for the treatment of genetic diseases.

CRISPR/Cas9 is a highly efficient genome editing tool that allows researchers to precisely cut and modify DNA sequences. It has been widely used in various fields, such as agriculture, medicine, and biotechnology, to improve crop yields, develop new therapies, and understand gene function.

In the area of genetic diseases, CRISPR/Cas9 has shown great promise in treating a wide range of conditions. Researchers have successfully used the technology to correct genetic mutations that cause diseases such as cystic fibrosis, sickle cell anemia, and Huntington's disease. By targeting the specific genetic defect, CRISPR/Cas9 can restore normal function to affected cells, potentially curing the disease.

Furthermore, CRISPR/Cas9 has the potential to be used for gene therapy, which involves introducing new genes into cells to treat genetic disorders. This approach has shown promising results in animal models and is currently being tested in human clinical trials.

Looking ahead, the future prospects for genome editing technologies are promising. With continued research and development, we can expect to see further improvements in the efficiency and specificity of CRISPR/Cas9, as well as the development of new genome editing tools. Additionally, the integration of genome editing technologies with other fields such as artificial intelligence and machine learning will open up new avenues for personalized medicine and disease treatment.

In conclusion, genome editing technologies have transformed the field of genetics and have the potential to revolutionize the treatment of genetic diseases. While there are still challenges to be addressed, such as safety and ethical considerations, the ongoing research and development in this area will likely lead to significant advancements in the years to come.

Weight: 560g
Dimension: 242 x 160 x 19 (mm)
ISBN-13: 9780367542863

UK and International shipping information

UK Delivery and returns information:

  • Delivery within 2 - 3 days when ordering in the UK.
  • Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
  • Returns policy: Return within 30 days of receipt for full refund.

International deliveries:

Shulph Ink now ships to Australia, Canada, France, Ireland, Italy, Germany, Spain, Netherlands, New Zealand, United States of America, Belgium, India, United Arab Emirates.

  • Delivery times: within 5 - 10 days for international orders.
  • Shipping fee: charges vary for overseas orders. Only tracked services are available for international orders.
  • Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.
View full details